Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd Watanabe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Masaru Matsuda - $2.45M of ARQT open-market activity in the last 12 months
- Howard G. Welgus - $2.18M of ARQT open-market activity in the last 12 months
- Patrick Burnett - $1.56M of ARQT open-market activity in the last 12 months
- Keith R. Leonard - $997K of ARQT open-market activity in the last 12 months
- Terrie Curran - $984K of ARQT open-market activity in the last 12 months
- Larry Todd Edwards - $968K of ARQT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Todd Watanabe?
Todd Watanabe is a corporate insider, tracked as Reporting Person's title: President and Chief Executive Officer, Director of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Todd Watanabe submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Todd Watanabe been buying or selling stock?
Recorded transactions: 2 open-market purchases ($21K) and 18 open-market sales ($6.01M) across all tracked filings.
Where can I see all of Todd Watanabe's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Todd Watanabe and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
